Instead of pushing a needle through skin and into subcutaneous tissue, you spray the reconstituted peptide solution into your nasal passages
Obes Res Clin Pract 9(3):301304 Vosoughi K et al (2021) Association of glucagon-like peptide 1 analogs and agonists administered for obesity with weight loss and adverse events: a systematic review and network meta-analysis
doi: 10.1016/j.biopha.2024.116553 162 PengSLuXLinFMaoNYuLZhuTet al
Fecal excretion of total carnitine was less than 1% of the administered dose.10 After attainment of steady state following 4 days of oral administration of CARNITOR Tablets (1980 mg q12h) or Oral Solution (2000 mg q12h) to 15 healthy male volunteers, the mean urinary excretion of levocarnitine during a single dosing interval (12h) was about 9% of the orally administered dose (uncorrected for endogenous urinary excretion)
2,3 Obesity is a complex, multifactorial condition influenced by various interrelated factors, including lifestyle, medications, genetics, medical conditions, gut hormones and psychological aspects